Kaloyannidis P, Ayyad A, Bahaliwah Z, Blowi B, et al. Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection. Bone Marrow Transplant 2021 May 4. pii: 10.1038/s41409-021-01318.
PMID: 33947981